No fifth dose in Mounjaro KwikPen: Lilly


Patients using Eli Lilly’s Mounjaro are being reminded that the KwikPen injection devices should be discarded after four doses  Residual liquid leftover after patients have injected their fourth dose of Mounjaro (tirzepatide) should not be consumed, manufacturer Eli Lilly says.  Following reports that a number of consumers have complained that they were unable to get

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Bayer Continuing Medical Education Series CPD Modules
Next Banks boost Sigma stakes